Effects of sigma ligands on the ability of rimcazole to inhibit PCP hsp70 induction

Brain Research Bulletin

Volumn 39, Issue 6, 1996, Pages 359-366

  Sharp, J W ^a   Williams, D S ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cyclazocine; Heat shock; hsp70; Pentazocine; Phencyclidine; Rat; Retrosplenial cortex; Rimcazole; Schizophrenia; Sigma receptor

Indexed keywords

CYCLAZOCINE; HEAT SHOCK PROTEIN 70; NEUROLEPTIC AGENT; PENTAZOCINE; PHENCYCLIDINE; PRECLAMOL; RIMCAZOLE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; DRUG BINDING; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; RAT; SCHIZOPHRENIA;

EID: 0029944764     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(96)00003-2     Document Type: Article

References (54)

1. Abou-Gharbia, M.; Ablordeppey, S. Y.; Glennon, R. A. Sigma receptors and their ligands. Ann. Rep. Med. Chem. 28:1-10; 1993.
2. Allen, H. L.; Iversen, L. L. Phencyclidine, dizocilipine, and cerebrocortical neurons. Science 247:221; 1990.
3. Beart, P. M.; O'Shea, R. D.; Manallack, D. T. Regulation of sigma-receptors: High-and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-di-(2-tolyl) guanidine. J. Neurochem. 53:779-788; 1989.
4. 3H] RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain. J. Pharmacol. Exp. Ther. 271:484-493; 1994.
5. Bonner, T. I. New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 10:11-15; 1989.
6. 3H] (+)-pentazocine, a highly selective sigma ligand. Prog. Clin. Biol Res 328:117-120; 1990.
7. Bowen, W. D.; Hellewell, S. B.; McGarry, K. A. Evidence for a multi-site model of the rat brain sigma receptor. Eur. J. Pharmacol. 163:309-318; 1989.
8. Bowen, W. D.; Walker, J. M.; de Costa, B. R.; Wu, R.; Tolentino, P. J.; Finn, D.; Rothman, R. B.; Rice, K. C. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-yrrolidinyl)cyclohexylamine (BD737 and BD738): Novel compounds with high affinity, selectivity and biological efficacy at sigma receptors. J. Pharmacol. Exp. Ther. 262:32-40; 1992.
9. Ceci, A.; Smith, M.; French, E. D. Activation of the A sub(10) mesolimbic system by the sigma -receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. Eur. J. Pharmacol. 154:53-57; 1988.
10. Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634; 1988.
11. -+ influx and beating rate in cultured cardiac myocytes. J. Pharmacol. Exp. Ther. 269:1300-1309; 1994.
12. Ferris, R. M.; Tang, F. L.; Chang, K.-J.; Russel, A. Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain. Life Sci. 38:2329-2337; 1986.
13. Gonzalez, M. F.; Shiraishi, K.; Hisanaga, K.; Sagar, S. M.; Mandabach, M.; Sharp, F. R. Heat shock proteins as markers of neural injury. Brain Res. Mol. Brain Res. 6:93-100; 1989.
14. 3H] dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 271:212-219; 1994.
15. Gundlach, A. L.; Largent, B. L.; Snyder, S. H. Phencyclidine and sigma opiate receptors in brain: Biochemical and autoradiographic differentiation. Eur. J. Pharmacol. 113:465-466; 1985.
16. 1H]DuP 734), a novel sigma receptor ligand. Brain Res. 598:76-86; 1992.
17. Hudzik, T. J. Sigma ligand-induced emesis in the pigeon. Pharmacol. Biochem. Behav. 41:215-217; 1992.
18. Itzhak, Y. Multiple affinity binding states of the sigma receptor: Effect of GTP-binding protein-modifying agents. Mol. Pharmacol. 36:512-517; 1989.
19. Itzhak, Y.; Stein, I. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: Further evidence for multiple sigma binding sites. Brain Res. 566:166-172; 1991.
20. Iyengar, S.; Wood, P. L.; Mick, S. J.; Dilworth, V. M.; Gray, N. M.; Farah, J. M.; Rao, T. S.; Contreras, P. C. (+)3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: Evidence for subtypes, in vivo. Neuropharmacology 30:915-922; 1991.
21. Jackson, D. M.; Johansson, C.; Lindgren, L. M.; Bengtsson, A. Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol. Biochem. Behav. 48:465-471; 1994.
22. Karbon, E. W.; Enna, S. J. Pharmacological characterization of sigma binding sites in guinea pig brain membranes. Adv. Exp. Med. Biol. 287:51-59; 1991.
23. Kemp, J. A.; Foster, A. C.; Wong, E. H. F. Noncompetitive antagonists of excitatory amino acid receptors. Trends Neurosci. 10:294-298; 1987.
24. Klein, M.; Musacchio, J. M. High-affinity dextromethorphan and (+)-3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine binding sites in rat brain: Allosteric effects of ropizine. J. Pharmacol. Exp. Ther. 260:990-999; 1992.
25. Klepstad, P.; Maurset, A.; Moberg, E. R.; Oye, I. Evidence of a role for NMDA receptors in pain perception. Eur. J. Pharmacol 187:513-518; 1990.
26. Largent, B. L.; Wikstrom, H.; Snowman, A. M.; Snyder, S. H. Novel antipsychotic drugs share high affinity for the sigma receptor. Eur. J. Pharmacol. 155:354-347; 1988.
27. Leysen, J. E.; Janssen, P. M.; Gommeren, W.; Wynants, J.; Pauwels, P. J.; Janssen, P. A. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. Mol. Pharmacol. 41:494-508; 1992.
28. Mattson, M. P.; Rychlik, B.; Cheng, B. Degenerative and axon-altering effects of phencyclidine in human fetal cerebral cortical cells. Neuropharmacology 31:279-291; 1992.
29. Maurset, A.; Oye, I. [Ketamine: Clinically useful - pharmacologically interesting]. Nord. Med 105:182-186; 1990.
30. 3H) SKF-10,047 to sigma sites. Eur. J. Pharmacol. 180:361-364; 1990.
31. 2+ homeostasis in hippocampal neurons in vitro. Mol. Pharmacol. 35:671-680; 1989.
32. Ogawa, S.; Okuyama, S.; Araki, H.; Otomo, S. Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction. Eur. J. Pharmacol. 263:9-15; 1994.
33. Okuyama, S.; Imagawa, Y.; Sakagawa, T.; Nakazato, A.; Yamaguchi, K.; Katoh, M.; Yamada, S.; Araki, H.; Otomo, S. NE-100, a novel sigma receptor ligand: Effect on phencyclidine-induced behaviors in rats, dogs and monkeys. Life Sci. 55:PL133-PL138; 1994.
34. Olney, J. W.; Labruyere, J.; Price, M. T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362; 1989.
35. Olney, J. W.; Labruyere, J.; Wang, G.; Wozniak, D. F.; Price, M. T.; Sesma, M. A. NMDA antagonists neurotoxicity: Mechanism and prevention. Science 254:1515-1518; 1991.
36. Popoli, P.; Pezzola, A.; Benedetti, M.; Scotti de Carolis, A. Verapamil and flunarizine inhibit phencyclidine-induced effects: An EEG and behavioural study in rats. Neuropharmacology 31:1185-1191; 1992.
37. Popoli, P.; Pezzola, A.; Scotti de Carolis, A. Influence of non-L-type calcium channel antagonists on phencyclidine-induced effects in rats. Life Sci. 52:2055-2061; 1993.
38. Richards, M. H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem. Pharmacol. 42:1645-1653; 1991.
39. Rothman, R. B. PCP site 2: A high affinity MK-801-insensitive phencyclidine binding site. Neurotoxicol. Teratol. 16:343-353; 1994.
40. 3H] 1,3-di (2-tolyl) guanidine of two high affinity binding sites in guinea pig brain: Evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. Mol. Pharmacol. 39:222-232; 1991.
41. Sagratella, S.; Scotti de Carolis, A.; Pezzola, A.; Popoli, P. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat. Psychopharmacology (Berlin) 105:485-491; 1991.
42. Sharp, F. R.; Butman, M.; Wang, S.; Koistinaho, J.; Graham, S. H.; Sagar, S. M.; Noble, L.; Berger, P.; Longo, F. M. Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J. Neurosci. Res. 33:605-616; 1992.
43. Sharp, F. R.; Jasper, P.; Hall, J.; Noble, L.; Sagar, S. M. MK-801 and ketamine induce heat shock protein HSP70 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30:801-809; 1991.
44. Sharp, J. W.; Sagar, S. M.; Sharp, F. R. MK801 induces the 72kDa heat shock protein and Fos in the cingulate gyrus. Neurosci. Abstr. 16:1122; 1990.
45. Simpson, M. D.; Slater, P.; Royston, M. C.; Deakin, J. F. Alterations in phencyclidine and sigma binding sites in schizophrenic brains: Effects of disease process and neuroleptic medication. Schizophren. Res. 6:41-48; 1991.
46. Snyder, S. H.; Largent, B. L. Receptor mechanisms in antipsychotic drug action: Focus on sigma receptors. Neuropsychiatry 1:7-15; 1989.
47. Sonders, M. S.; Keana, J. F. W.; Weber, E. Phencyclidine and psychomimetic sigma opiates:recent insights into their biochemical and physiological site of action. Trends Neurosci. 11:37-40; 1988.
48. Su, T. P. Delineating biochemical and functional properties of sigma receptors: Emerging concepts. Crit. Rev. Neurobiol. 7:187-203; 1993.
49. Su, T. P.; Wu, X. Z.; Cone, E. J.; Shukla, K.; Gund, T. M.; Dodge, A. L.; Parish, D. W. Sigma compounds derived from phencyclidine: Identification of PRE-084, a new, selective sigma ligand. J. Pharmacol. Exp. Ther. 259:543-550; 1991.
50. Vass, K.; Welch, W. J.; Nowak, T. S., Jr. Localization of 70kD stress protein induction in gerbil brain after ischemia. Acta Neuropathol. 77:128-135; 1988.
51. Vilner, B. J.; de Costa, B. R.; Bowen, W. D. Cytotoxic effects of sigma ligands: Sigma receptor-mediated alterations in cellular morphology and viability. J. Neurosci. 15:117-134; 1995.
52. Walker, J. M.; Bowen, W. D.; Walker, F. O. Matsumoto, R. R.; De Costa, B.; Rice, K. C. Sigma receptors: Biology and function. Pharmacol. Rev. 42:355-402; 1990.
53. Watkins, J. C.; Olverman, H. J. Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci. 10:265-272; 1987.
54. 3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum. Life Sci. 55:PL389-PL395; 1994.